A study of the safety and efficacy of a new treatment for non-infectious intermediate uveitis
Phase of Trial: Phase II/III
Latest Information Update: 18 Apr 2011
At a glance
- Drugs Dexamethasone (Primary)
- Indications Intermediate uveitis
- Focus Therapeutic Use
- Sponsors Allergan
- 26 May 2009 Additional locations identified as reported by ClinicalTrials.gov.
- 26 May 2009 Actual patient number (229) added as reported by ClinicalTrials.gov.
- 26 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.